| Title： | Chinese Public Guideline for the Management of Chronic Kidney Disease (CKD) Risk |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | The guidelines apply to hospitals at all levels, ground-level community health centers, Centers for Disease Control and prevention and other health institutions. The users of the guidelines are the general population of all ethnic groups and regions in the country. |
| Evidence classification method： | GRADE method will be used to evaluate certainty (quality) of evidence associated with the risk of gastric cancer. According to GRADE method, the quality of evidence is classified into four grades: high, moderate, low and very low. Five downgrading factors (risk of bias, inconsistency, indirectness, imprecision, and publication bias) and three escalation factors (large effect, plausible confounding, and dose response gradient) are considered in the evidence grading process. After grading the evidence, the evidence will be presented through the "summary of findings" table. |
| Development unit： | Chinese Health Risk Management Collaboration (CHRIMAC) - Chronic Kidney Disease (CKD) Group |
| Registration time: | 2023-12-22 |
| Registration number： | PREPARE-2023CN444 |
| Purpose of the guideline: | There is a lack of evidence-based guidelines to guide the public on chronic kidney disease risk assessment and targeted preventive interventions. Therefore, the purpose of this guideline is to systematically summarize the evidence related to chronic kidney disease risk assessment and preventive interventions for high-risk populations, and to form a guideline to promote effective chronic kidney disease prevention and control. |
Latest registration
